Commercial
NextConsensus
Estimates how likely a guideline, label, or coverage decision is to change by a set date.
I built and led healthcare products at Doximity, Transcarent, and CancerCompass, and co-founded Andwise. Now I build tools for the questions that come after launch: has the evidence behind a decision changed, what was an AI agent approved to do, and did a correction reach the people who acted on the error?
300,000+
calls on an average workday
What I’d keep If the person choosing carries the risk, adoption can come before official approval. If the risk is clinical, it can’t.
Read full case study →
What I’d keep Name the trigger, the owner, and the notification before the problem arrives.
Read full case study →Commercial
Estimates how likely a guideline, label, or coverage decision is to change by a set date.
Essays
I write at The Crumple Zone about who absorbs an institution’s failures and who can make it correct them. Selected writing →
Proposed AI standards
I wrote the Ethotechnics framework, an open set of proposed standards for recording approval, challenges, and corrections. ethotechnics.org
Whether a record can carry a real dispute end to end: an agent acts, a person challenges the action, and the correction reaches every decision that depended on it.
You are waiting on a guideline, label, or coverage decision
NextConsensus estimates how likely it is to change by a set date.
NextConsensus → Ask NextConsensus about a decision (opens in a new tab)
You have a product that works and a review standing between it and its users
I help teams get a working AI model through hospital review and into the workflow clinicians already use.
Framework → Ask about an advisory, fractional, or founding role →
You have a record of decisions you want tested
I work with researchers and institutions on how they recognize and correct failure, as commissioned research or an evidence review.
Anything else: kanav@kanav.net
Revised